Modulating the gut microenvironment as a treatment strategy for irritable bowel syndrome: a narrative review
Gut Microbiome · 2022
DOI: 10.1017/gmb.2022.6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Gut Microbiome, 2022. Verfasst von Cristina Iribarren und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Medical Research Council, Sahlgrenska Academy at University of Gothenburg, ALF-agreement.
Abstract (Originalsprache)
Irritable bowel syndrome (IBS) is a disorder of gut–brain interaction with a complex pathophysiology. Growing evidence suggests that alterations of the gut microenvironment, including microbiota composition and function, may be involved in symptom generation. Therefore, attempts to modulate the gut microenvironment have provided promising results as an indirect approach for IBS management. Antibiotics, probiotics, prebiotics, food and faecal microbiota transplantation are the main strategies for alleviating IBS symptom severity by modulating gut microbiota composition and function (eg. metabolism), gut barrier integrity and immune activity, although with varying efficacy. In this narrative review, we aim to provide an overview of the current approaches targeting the gut microenvironment in order to indirectly manage IBS symptoms.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Center for Functional GI and Motility Disorders, University of North Carolina, Chapel Hill, NC, USA.
ORCID-Profile: Magnus Simrén
Förderung
- Swedish Medical Research Council
- Sahlgrenska Academy at University of Gothenburg
- ALF-agreement
- Regional Executive Board, Region Västra Götaland
- Faculty of Medicine at University of Gothenburg
Zitieren
APA
Iribarren, C., Maasfeh, L., Öhman, L., & Simrén, M. (2022). Modulating the gut microenvironment as a treatment strategy for irritable bowel syndrome: a narrative review. Gut Microbiome. https://doi.org/10.1017/gmb.2022.6
Vancouver
Iribarren C, Maasfeh L, Öhman L, Simrén M. Modulating the gut microenvironment as a treatment strategy for irritable bowel syndrome: a narrative review. Gut Microbiome. 2022. doi:10.1017/gmb.2022.6
BibTeX
@article{Iribarren2022,
author = {Iribarren, Cristina and Maasfeh, Lujain and Öhman, Lena and Simrén, Magnus},
title = {Modulating the gut microenvironment as a treatment strategy for irritable bowel syndrome: a narrative review},
journal = {Gut Microbiome},
year = {2022},
doi = {10.1017/gmb.2022.6}
}
EUVIMED